This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients. It features a bicyclic structure containing ether and heterocyclic rings, with defined stereochemistry.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Tert-Butyl (4aS,7aS)-octahydropyrrolo[3,4-b]morpholine-6-carboxylate
pharmaceutical intermediate
4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline
pharmaceutical intermediate
Ethyl hydrazinoacetate hydrochloride
pharmaceutical intermediate
(1R,2R,3R,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptan-3-amine
pharmaceutical intermediate
3'-Chloro-4'-aminoacetophenone
pharmaceutical intermediate
tert-butyl (4aR,7aS)-2,3,4a,5,7,7a-hexahydro-[1,4]dioxino[2,3-c]pyrrole-6-carboxylate
YTGMDYKVUYMIQK-DTORHVGOSA-N
CC(C)(C)OC(=O)N1C[C@@H]2[C@H](C1)OCCO2
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.